A Randomized Phase II Study of Adjuvant Concurrent Radiation and Chemotherapy Versus Radiation Alone in Resected High-Risk Malignant Salivary Gland Tumours
RATIONALE: Radiation therapy uses high-energy x-rays to kill tumour cells. Drugs used in
chemotherapy, such as cisplatin, work in different ways to stop the growth of tumour cells,
either by killing the cells or by stopping them from dividing. It is not yet known whether
radiation therapy is more effective when given together with chemotherapy or alone after
surgery in treating salivary gland tumours.
PURPOSE: This randomized phase II trial is studying radiation therapy with or without
chemotherapy to see how well it works in treating patients with high-risk malignant salivary
gland tumours that have been removed by surgery.
View this trial on ClinicalTrials.gov
Print this page and take it to your doctor to discuss your eligibilty and treatment options. Only your doctor can refer you to a clinical trial.
These resources are provided in partnership with the
Canadian Cancer Society